Static Chart Verrica Pharmaceuticals Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 24/05/2024 am IST			5-day change	1st Jan Change
8.35 ^USD	-7.73%		-8.74%	+14.07%

15/05	Verrica Pharmaceuticals Amends Licensing Agreement With Torii Pharmaceutical for Phase 3 Trial of Ycanth	MT
15/05	Verrica Pharmaceuticals Inc. Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study Ycanth for the Treatment of Common Warts	CI

Duration

Period